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Abstract
The labor-force participation rates of prime-age U.S. workers dropped in March
2020—the start of the COVID-19 pandemic—and have still not fully recovered. At
the same time, substance-abuse deaths were elevated during the pandemic relative
to trend indicating an increase in the number of substance abusers, and abusers of
opioids and crystal methamphetamine have lower labor-force participation rates than
non-abusers. Could increased substance abuse during the pandemic be a factor contributing to the fall in labor-force participation? Estimates of the number of additional
substance abusers during the pandemic presented here suggest that increased substance
abuse accounts for between 9 and 26 percent of the decline in prime-age labor-force
participation between February 2020 and June 2021.
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Introduction

There was a substantial decline in labor-force participation in the U.S. at the start of the
COVID-19 pandemic, recovery from which has been slow. The decline is in part due to
the exit and subsequent low rates of return of older workers (Bauer and Edelberg, 2021).
However, there has also been a large decline in the labor-force participation rate (LFPR)
of prime-age workers between ages 25 and 54. While there has been some recovery, as of
January 2022, the participation rate is still well below its pre-pandemic levels.
The dramatic drop and sluggish recovery in the labor supply of prime-age workers can be
seen in Figure 1. Early on in the pandemic, the LFPR dropped by about 3 percentage points,
and although two-thirds of that decline has recovered, the rate is still about 1 percentage
point below its pre-pandemic level. After its steady decline since the late 1990s, the LFPR
of prime-age workers was trending upward before the pandemic.1 The straight dashed line
in the figure shows the trend in labor-force participation over the January 2015 to February
2020 period. Assuming the prime-age LFPR would have increased at the same rate absent
the COVID-19 pandemic, the LFPR is about 1.6 percentage points below trend.
Figure 1: Labor-force participation rate, ages 25–54, January 2015 to January 2022
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Source: U.S. Bureau of Labor Statistics.
The COVID-19 epidemic hit the US during the middle of another major health crisis, the
1
See Binder and Bound (2019) and Abraham and Kearney (2020) for recent reviews on the decline in
labor-force participation in the U.S.
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opioid epidemic.2 The number of overdose deaths from opioids, but also other substances
like alcohol and methamphetamine (meth), increased dramatically with COVID-19 leading
the New York Times to refer to the COVID-19 epidemic as a “national relapse trigger”
(Hoffman, 26 March 2020). Opioid use is associated with lower labor-force participation
and employment.3 During the 2015–18 period, the LFPR of prime-age workers with an
opioid-use disorder was 70 percent, 13 percentage points lower than that of those without
a substance-use disorder. Meth use is associated with an even larger reduction in laborforce participation. Meth users’ LFPR during 2015–18 was 67 percent, 16 percentage points
lower than that of those without a substance-use disorder. If the increase in substanceabuse deaths during the COVID-19 epidemic reflects, partly or fully, a rise in the number of
people with substance-use disorder this rise is a potential source of the decline in labor-force
participation.4
Figure 2 shows the deaths rates associated with overdoses from different substances.5 The
solid blue line in the figure displays monthly deaths from narcotics, which covers various types
of opioids such as opium, heroin, fentanyl, and other natural and synthetic opioids, as well
as deaths from cocaine. The blue dashed line shows the trend and seasonal narcotic deaths
based on the pre-pandemic period.6 The red solid and dashed lines show the death rates,
actual and predicted, from alcohol (excluding those associated to drunk driving). Finally, the
black lines are deaths from psychostimulants, primarily crystal methamphetamine (meth).
Meth deaths have also been higher during the pandemic, although they have not been as
elevated relative to their exponentially increasing trend as narcotic and alcohol deaths.
While the number of overdose deaths is available up to June 2021, data on individuals
who abuse different substances is not available for the post-COVID period. The latest data
from the National Survey of Drug Use and Health (NSDUH) was published in October 2021
and covers drug use during 2019.7 The NSDUH classifies individuals as misusers of opioids
if they use any opioids without a prescription, use them for reasons other than directed
2

Since 2000, there have been more than 500,000 deaths from opioid overdose. Cutler and Glaeser (2021)
provides a review of the extensive empirical literature on the opioid crisis. A model of opioid abuse is
developed by Greenwood et al. (2022) to study its driving forces.
3
Krueger (2017), Aliprantis et al. (2019), Harris et al. (2020) and Powell (2021) exploit geographic variation in opioid exposure to study its impact on labor market outcomes.
4
Another potential source of sluggish labor-force recovery is lower responsiveness of the participation
rates of younger generations to wage growth as documented by Hotchkiss (2022).
5
Deaths involving multiple substances are double counted in the figure. However, this double counting is
largely offset by deaths from undetermined substances (not shown in the figure).
6
Following Mulligan (2022), the dashed trend plus seasonal lines are determined by regressing the log of
deaths from January 1999 to December 2019 on a quartic in time at the monthly frequency and month-ofyear dummies. The narcotics regressions also include indicator variables for dates ≥ January 2006 and dates
≥ January 2016. Large jumps in narcotics deaths are seen at these dates, which may be due to the increased
coverage of prescription drugs, including prescription opioids, through the introduction of Medicare Part D
and the increased availability of fentanyl in the U.S. illicit drug market, respectively. See Mulligan (2022)
and Council of Economic Advisers (US) (2010).
7
The National Survey on Drug Use and Health (NSDUH) is an annual nationwide survey that provides
national and state-level data on the use of tobacco, alcohol, illicit drugs (including the non-medical use of
prescription drugs), and mental health in the United States. The survey represents the age 12 and over civilian non-institutionalized population of the United States for each state and the District of Columbia (D.C.).
The NSDUH is directed by the Substance Abuse and Mental Health Services Administration (SAMHSA),
an agency in the U.S. Department of Health and Human Services (HHS).
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Figure 2: Annual rate of drug and alcohol deaths, ages 25–54, January 2010 to June 2021.
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Source: Mulligan (2022), CDC database of death certificates. Narcotics and
psychostimulants are primarily opioids and methamphetamine, respectively. They are
selected on MCD codes. Alcohol-induced deaths are selected on UCD codes. Trends use
1999–2019 data and include seasonal factors.
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by a physician, or use them in greater amounts or more often than prescribed during the
past 12 months. Individuals consuming alcohol, heroin or meth are classified as misusers
by default.8 Misusers are then asked follow-up questions to determine whether they have a
disorder. To be labeled as someone with a disorder, substance abuse must interfere with a
person’s daily life. People with a disorder and abusers are used interchangeably below. Once
the additional number of abusers is estimated, the gap in labor-force participation between
abusers and non-abusers can shed light on the extent to which higher alcohol and drug use
during the epidemic is behind the decline in aggregate labor-force participation.

2

Higher Drug Use during the Epidemic

The increase in substance abuse deaths during the COVID-19 pandemic could be due to an
increase in the death rate of substance abusers or an increase in the number of abusers or
some combination of the two. To see this, let Ut be the number of users at time t, and Dt be
the number of deaths. Let δ(mt , ut ) be the death rate conditional on being an abuser which
might depend on medical technology or environment (mt ) and usage (ut ). The number of
deaths at time t must equal the number of abusers at time t times the death rate conditional
on abuse, or Dt = δ(mt , ut )Ut .
First, suppose that the death rate of abusers, δ(mt , ut ), did not change during the pandemic, and the entire increase in deaths is driven by an increase in the number of abusers,
Ut . Why might the number of abusers have increased? There are several potential reasons.
Increased anxiety, isolation, joblessness, and other factors caused by the pandemic could have
led to an increased desire to abuse drugs and/or alcohol (Weiner, 2020). For alcohol, the
shift to drinking at home from drinking in restaurants and bars reduced the cost per ounce,
which may have led to higher quantities consumed.9,10 During the pandemic, there were also
fewer options for ways to spend both time and money. Moreover, like many leisure goods,
abusing drugs and alcohol requires time.11 This is especially true when accounting for both
the time spent abusing the substances and the time spent recovering from their usage. Given
this complementarity between time and drugs and alcohol, declines in the value of time may
have effectively led to decreases in the total cost of substance abuse and, consequently, an
increase in the number of abusers. Once started, drug and alcohol abuse is difficult to stop
for many people. For this reason, the complementarity between time and drug or alcohol
use can also explain why an increase in substance abuse during the pandemic would mean
lower labor-force participation rates even after the pandemic has ended.12
8

This reflects the fact that in contrast to prescription opioids, a reference, or accepted, level of consumption
does not exist.
9
According to Nielssen, sales of alcohol in stores increased by 27% in the U.S. between mid-March and
mid-May of 2020 (Valinsky, 26 May 2020).
10
Mulligan (2022) argues that the shift away from heroin and prescription opioids to fentanyl during the
epidemic (discussed below) led to a reduction in the price per morphine milligram equivalent of opioids which
similarly may have led to higher levels of consumption.
11
The notion that the consumption of leisure goods is time intensive is not new. It was used, for instance,
by Kopecky (2011) to understand the rise in retirement in the U.S. in the 20th century.
12
There is some evidence that additional users drove the increase in opioid deaths during the pandemic.
The Center for Disease Control and Prevention (2020), for example, shows that the rise in deaths associated
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Table 1: Total deaths and imputed abusers ages 25–54 by substance assuming no change in
the death rate conditional on abuse, April 2020 – June 2021
Opioids

Meth

Alcohol

Total

Number of deaths
Actual
Predicted from trend + seasonals
Additional deaths

69,342
54,522
14,820

32,363
29,662
2,702

27,683
19,848
7,835

129,389
104,032
25,356

Pre-pandemic annual death rate

0.605%

0.266%

0.260%

Alive with substance use disorder (1000s)
Actual
Predicted from trend + seasonals
Additional number of abusers

9,166
7,207
1,959

9,735
8,922
813

8,503
6,096
2,406

27,404
22,226
5,178

If the increase in deaths is entirely driven by a rise in the number of abusers, how large
is the impact on the LFPR? To answer this question, requires calculating the additional
number of abusers of opioids, meth, and alcohol. As the equation above shows, the number
of abusers of a substance can be imputed by dividing the number of deaths by the death
rate, i.e., Ut = Dt /δ(mt , ut ). The gap between the LFPRs of abusers and non-abusers then
provides an estimate of the drop in the aggregate LFPR due to the higher number of abusers
during the epidemic.
The first row of Table 1 reports the cumulative number of deaths from opioids, meth,
and alcohol between April 2020 and June 2021 for individuals ages 25 to 54.13 The second
row reports the number of deaths predicted using the pre-pandemic trend and seasonal
components in Figure 2. Subtracting the second row from the first row gives an estimate of
the additional number of deaths that occurred due to the COVID-19 pandemic. These are
reported in the third row. There were 69,342 opioid deaths between April 2020 and June
2021, 14,820 of which were above the level predicted by the pre-pandemic trends. Similarly
there were 2,702 excess meth-related deaths and 7,835 excess alcohol-related deaths. In total,
during this period there were an additional 25,356 drug and alcohol deaths.
Next turn attention to the death rates. Under the assumption that these rates did not
change during the pandemic, they are determined by dividing the number of deaths prepandemic by the number of abusers. These death rates, taken from Mulligan (2022), are
reported in the fourth row of Table 1. The death rate for opioids, about 0.6 percent, is
much higher than those for meth and alcohol, about 0.26–0.27 percent. Further details are
provided in Appendix A.
with fentanyl was mainly in Western states, while historically, fentanyl-related deaths were concentrated in
the East. Kim et al. (2021), focusing on opioid-related deaths in Illinois, document that during the pandemic
a larger fraction of opioid-overdose deaths had no prior opioid use disorder treatment.
13
June 2021 is the last month of available data on deaths. The analysis uses opioid overdose deaths,
since deaths from cocaine overdose, the remaining part of narcotics, have not experienced a jump during the
epidemic.
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Table 2: Impacts of substance abuse on labor-force participation

LFPR of non-abusers - LFPR of abusers (percentage points)
Out of labor force due to substance abuse disorder (1,000s)
Actual
Predicted from trend + seasonals
Additional number out of labor force

Opioids Meth
13.2
16.3

1,211
952
259

1,585
1,453
132

Alcohol
0.0

Total
7.6

0
0
0

2,796
2,405
391

The source for relative LFPRs is NSDUH.

For each substance, the number of abusers (individuals with substance-use disorder) can
now be inferred by simply dividing the number of deaths by the pre-pandemic death rates.14
As the bottom three rows of Table 1 report, more than 27 million prime-age individuals are
estimated to have a substance abuse disorder with more than 5 million of these individuals,
23%, being additional substance abusers above the expected level based on past trend and
seasonal effects.15

3

Substance Abuse and the Decline in LFP

Next turn to how much substance abuse lowers labor-force participation. The first row of
Table 2 shows the difference between the LFPRs of opioid, meth, and alcohol non-abusers
and abusers. The LFPRs are calculated from the 2015–2018 NSDUH for prime-age individuals who either exhibit a disorder from using a particular substance or do not have a
substance-disorder.16 The LFPR of individuals with an opioid-use disorder is 69.7 which is
13.2 percentage points below the prime-age rate for individuals who do not have a substanceuse disorder of 82.9%. Similarly, the LFPR for individuals with meth-use disorder is 66.7%
which is 16.3 percentage points below the rate for individuals without a substance-use disorder. By contrast, there is no difference in LFPRs between alcohol abusers and non-abusers.
Since the data shows no impact of alcohol abuse on labor-force participation, the increase
in alcohol abusers will not have any impact on the number of additional individuals out of
the labor force. For each substance, multiplying the number of abusers in Table 1 by the
difference between the LFPR of abusers and non-abusers gives an estimate of the number
of prime-age individuals who are out of the labor force (LF) due to substance abuse. For
example, multiplying the 1,96 million additional opioid abusers reported in Table 1 by 13.2
14

Since total deaths are for a 15 month period (April 2020 through June 2021), the annual death rates are
multiplied by 15/12.
15
For alcohol, using deaths of individuals ages 25-54 to impute the number of abusers likely undercounts
the total number of abusers since many alcohol deaths are not acute. Alternatively, one could use alcohol
deaths for all ages assuming they are proportional to the rise in the number of prime-age alcohol abusers.
Under this assumption, the number of additional prime-age alcohol abusers increases by 4.2 million instead
of the 2.4 million reported in Table 1.
16
The age of respondents in the public-use version of the NSDUH is reported in age ranges. The numbers
in Table 2 for prime-age, 25–54, individuals are averages of the ratios for age groups 26–49 and 24–64.
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Table 3: Number of prime-age labor-force participants in February 2020, and number and
predicted number in June 2021.
Feb. 2020 Jun. 2021
125.95
126.10

Population aged 25-54 (millions)
LFP 25-54
Number of 25-54 in LF (millions)
Decline in LF from Feb 2020 (millions)
Predicted LFP 25-54
Predicted number of 25-54 (millions)
Decline in LF from predicted (millions)

83.0%
104.54

81.7%
103.02
1.51
83.3%
105.04
2.02

percentage points implies that about 259,000 additional people are not in the labor force due
to elevated levels of opioid abuse. The estimates indicate that all together there are over 2.7
million prime-age individuals not participating in the labor market due to substance abuse,
391 thousand of which are additional non-participants due to the elevated levels of abuse
during the COVID-19 pandemic.
Table 3 summarizes the impact of the COVID-19 epidemic on labor-force participation
of prime-age workers. Due to a 1.3 percentage point lower participation rate, there were
1.51 million fewer prime-age individuals in the labor force in June 2021 than in February
2020. The sixth row of the table reports the number of individuals predicted to be in the
labor force in June 2021 using the pre-pandemic trend. Relative to the predicted number
of 105.04 million, there were 2.02 million fewer participants.17 How many of these missing
workers might be attributed to drug abuse?
Under the assumption of no change in the death rate of abusers, the increase in opioid and
meth usage during the pandemic accounts for a sizable fraction of the decline in LFPRs. The
results are reported as the upper bound estimates in Table 4. These shares are determined by
taking the estimated 391 thousand additional individuals not participating due to substance
abuse reported in Table 2 and dividing it by the declines in the size of the labor force reported
in Table 3. Additional non-participants due to elevated substance abuse are 25.8 percent of
the 1.51 million person decline in the labor force between February 2020 and June 2021 and
19.4 percent of the decline from the predicted June 2021 levels based on the pre-pandemic
trend. Next, we provide a lower-bound estimate assuming that the rise in opioid deaths
during the pandemic was due to increased opioid use of existing abusers rather than a surge
in the number of abusers.
17

Labor-force participation levels did not fully recover after June 2021 as Figure 1 shows. As of January
2022, the most recent date for which labor-force participation rates are available, the number of prime-age
individuals in the labor force is still 0.26 million below the February 2020 level and 2.03 million below levels
predicted by the pre-pandemic trend.

8

Table 4: Estimated share of the decline in the size of the labor force between Feb. 2020 and
June 2021 that is due to increased substance abuse

Share of decline from Feb. 2020 level
Share of decline from predicted June 2021 level

4

Upper bound
25.8%
19.4%

Lower bound
8.7%
6.6%

Were Death Rates Constant during the Epidemic?

The calculations have so far assumed that the death rate δ(mt , ut ) was constant during the
epidemic. This, of course, is a strong assumption. One concern, for example, might be that
medical services for people with substance disorders were less available or effective during the
pandemic, which would lower mt and increase the death rate. Yet, there is no clear evidence
that this was the case, at least not for those who had a disorder before the pandemic. In a
survey of centers prescribing medication for opioid use disorder (OUD), Uscher-Pines et al.
(2020) find that there was a quick move to telemedicine.18 Focusing on patients, Huskamp
et al. (2020) also documents that patients with an OUD did not have any trouble with
medication refills or clinical visits.
Still, fentanyl usage increased rapidly during the pandemic, affecting ut and, as a result,
the death rate. Figure 3 shows the ratio of heroin, illicit prescription (Rx) opioid, and synthetic opioid (primarily fentanyl) deaths to the overall narcotics death trend for individuals
ages 18 to 69. The figure shows that the increase in narcotics deaths was driven by increased
fentanyl usage relative to heroin and prescription opioid abuse. Consistently, based on an
analysis of a large number of urine samples before and during the epidemic, Niles et al. (2021)
find that fentanyl positivity rates increased by more than 50 percent during the pandemic.
Since fentanyl usage is associated with a higher death rate than that of heroin and other
organic forms of opioids, the rapid increase in fentanyl usage may have led to a higher death
rate among narcotic abusers.
Imagine that the number of opioid users did not change, i.e. Ut = Ut+1 , and instead, all
of the additional opioid deaths during the pandemic were driven by a higher death rate of
abusers due to a shift in usage from organic opioids to fentanyl. While this is clearly a very
strong assumption, it provides a lower bound on the likely impact of the increase in substance
abuse on LFPRs. If the number of narcotic abusers did not increase (and synthetic opioids
do not inhibit labor supply more than organic ones), then the only impact on LFPRs is from
the increase in the number of meth users. According to Table 2, the number of additional
individuals out of the labor force due to additional meth use during the pandemic is 132
thousand which accounts for 8.7 percent of the decline in labor-force participation between
February 2020 and June 2021 and 6.6 percent of the decline in labor-force participation
relative to the pre-pandemic trend. These lower bound estimates of the effect of increased
substance abuse during the pandemic on labor-force participation are reported in the second
column of Table 4.
18

For a discussion on COVID-19 related measures that waived in-person assessment for the OUD prescriptions, see Wakeman et al. (2020).
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Conclusion

Using data on substance abuse deaths, increased substance abuse during the COVID-19
pandemic is estimated to account for between 9 and 26 percent of the decline in prime-age
labor-force participation between February 2020 and June 2021. A decline that, as of January
2022, has still not fully recovered. Relative to levels predicted using the pre-pandemic trend,
estimates indicate that increased substance abuse accounts for 7 to 19 percent of the decline.
Interestingly, the falls in labor-force participation in early 2020 were larger for those
without a college degree. The LFPR of non-college individuals dropped by 3.9 percentage
points compared to a 2.8 percentage point drop for those with a college degree. Non-college
labor-force participation has also been slower to rebound. As of January 2022, more than 70
percent of the initial fall in the LFPR of college graduates has recovered with the rate now
less than 1 percentage point below levels predicted by the pre-pandemic trend. In contrast,
less than half of the initial drop for non-college has recovered. As of January 2022, the
non-college rate is still 2.4 percentage points below trend.
The large initial drop in labor-force participation by non-college individuals and its slow
recovery may be due to differential rates of increase in substance abuse by education during
the pandemic. Rates of opioid abuse are more than three times higher, and rates of meth
abuse nearly six times higher, among those without a college degree. Given their higher
10

prevalence for illicit drug use, the extent of drug abuse may have increased more for noncollege individuals during the pandemic leading to larger negative effects on their labor-force
participation.

A

Appendix: Pre-Pandemic Death Rates

The death rates reported in Table 1 are calculated as follows. Start with alcohol. In the
NSDUH, there were 14.818 million individuals above age 18 with alcohol use disorder in 2018
and 14.504 million in 2019 (Center for Behavioral Health Statistics and Quality (2020), Table
5.2.A). In the same years, 37,329 and 39,043 individuals in the same age group died due to
alcohol-induced causes. Dividing the average number of deaths in 2018 and 2019 (38,186)
by the average number of users (14,661 million) gives an annual death rate from alcohol
abuse of 0.26 percent. For the death rate from opioids, Barocas (2018) estimates that there
were 254,127 individuals of all ages with opioid disorder in Massachusetts between 2014 and
2015.19 The number of opioid-related overdose deaths for the same years was 1,538. Again,
dividing the average number of deaths by the average number of users gives an annual death
rate of 0.605 percent. Finally, following Mulligan (2022), deaths from opioid disorder are
assumed to be 2.3 times more deadly than meth use disorder; i.e., the death rate for meth
is assumed to be 0.605/2.3 percent.

19
Barocas (2018) uses administrative data to estimate the number of individuals with opioid use disorder,
which overcomes potential underreporting of opioid use disorder in the NSDUH.
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